185 related articles for article (PubMed ID: 17598110)
21. Tumor hypoxia: the role of nuclear medicine.
Cook GJ; Fogelman I
Eur J Nucl Med; 1998 Apr; 25(4):335-7. PubMed ID: 9643970
[No Abstract] [Full Text] [Related]
22. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data.
Kelly CJ; Brady M
Phys Med Biol; 2006 Nov; 51(22):5859-73. PubMed ID: 17068369
[TBL] [Abstract][Full Text] [Related]
23. Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls.
Herrmann K; Buck AK
PET Clin; 2014 Jul; 9(3):331-8. PubMed ID: 25030396
[TBL] [Abstract][Full Text] [Related]
24. [Quality control of PET imaging: from study to diagnosis].
Daisaki H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
[No Abstract] [Full Text] [Related]
25. Fluorinated amino acids for tumour imaging with positron emission tomography.
Laverman P; Boerman OC; Corstens FH; Oyen WJ
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):681-90. PubMed ID: 11976809
[TBL] [Abstract][Full Text] [Related]
26. Non-[18F]FDG PET in clinical oncology.
Groves AM; Win T; Haim SB; Ell PJ
Lancet Oncol; 2007 Sep; 8(9):822-30. PubMed ID: 17765191
[TBL] [Abstract][Full Text] [Related]
27. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
28. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
[TBL] [Abstract][Full Text] [Related]
29. Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.
Wagner S; Kopka K
Recent Results Cancer Res; 2013; 187():107-32. PubMed ID: 23179879
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents.
Wang L; Qu W; Lieberman B; Ploessl K; Kung HF
Bioorg Med Chem Lett; 2010 Jun; 20(12):3482-5. PubMed ID: 20529679
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
32. [Oncology PET imaging].
Inubushi M
Igaku Butsuri; 2014; 34(1):3-9. PubMed ID: 25199271
[TBL] [Abstract][Full Text] [Related]
33. Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.
Rizvi SN; Comans EF; Boellaard R; van Tinteren H; Hoekstra OS
Eur J Cancer; 2010 Aug; 46(12):2150-8. PubMed ID: 20561780
[TBL] [Abstract][Full Text] [Related]
34. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
Sanz-Viedma S; Torigian DA; Parsons M; Basu S; Alavi A
Rev Esp Med Nucl; 2009; 28(3):159-66. PubMed ID: 19558958
[No Abstract] [Full Text] [Related]
35. [Positron emission tomography 2008 in Germany - results of the query and current status].
Kotzerke J; Oehme L; Lindner O; Hellwig D;
Nuklearmedizin; 2010; 49(2):58-64. PubMed ID: 20198277
[TBL] [Abstract][Full Text] [Related]
36. Imaging tumour hypoxia with positron emission tomography.
Fleming IN; Manavaki R; Blower PJ; West C; Williams KJ; Harris AL; Domarkas J; Lord S; Baldry C; Gilbert FJ
Br J Cancer; 2015 Jan; 112(2):238-50. PubMed ID: 25514380
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomographic imaging of angiogenesis and vascular function.
Laking GR; Price PM
Br J Radiol; 2003; 76 Spec No 1():S50-9. PubMed ID: 15456714
[TBL] [Abstract][Full Text] [Related]
38. FMISO as a Biomarker for Clinical Radiation Oncology.
Zschaeck S; Steinbach J; Troost EG
Recent Results Cancer Res; 2016; 198():189-201. PubMed ID: 27318688
[TBL] [Abstract][Full Text] [Related]
39. Methodological aspects on hypoxia PET acquisition and image processing.
Thorwarth D; Mönnich D; Zips D
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):235-43. PubMed ID: 24045620
[TBL] [Abstract][Full Text] [Related]
40. FDG and Beyond.
De Ruysscher D; Haustermans K; Thorwarth D
Recent Results Cancer Res; 2016; 198():163-73. PubMed ID: 27318686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
